Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dynamics of Phenotypic Heterogeneity Associated with EMT and Stemness during Cancer Progression
Mohit Kumar Jolly, Toni Celià-Terrassa
Journal of Clinical Medicine (2019) Vol. 8, Iss. 10, pp. 1542-1542
Open Access | Times Cited: 123

Showing 1-25 of 123 citing articles:

Linking EMT programmes to normal and neoplastic epithelial stem cells
Arthur W. Lambert, Robert A. Weinberg
Nature reviews. Cancer (2021) Vol. 21, Iss. 5, pp. 325-338
Closed Access | Times Cited: 404
Epithelial‐to‐mesenchymal transition in oral squamous cell carcinoma: Challenges and opportunities
Zihang Ling, Bin Cheng, Xiaoan Tao
International Journal of Cancer (2020) Vol. 148, Iss. 7, pp. 1548-1561
Open Access | Times Cited: 163
MiR-375 reduces the stemness of gastric cancer cells through triggering ferroptosis
Haiwei Ni, Hai Qin, Cheng Sun, et al.
Stem Cell Research & Therapy (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 139
Phenotypic heterogeneity driven by plasticity of the intermediate EMT state governs disease progression and metastasis in breast cancer
Meredith S. Brown, Behnaz Abdollahi, Owen M. Wilkins, et al.
Science Advances (2022) Vol. 8, Iss. 31
Open Access | Times Cited: 98
Cell-intrinsic and microenvironmental determinants of metastatic colonization
Arthur W. Lambert, Yun Zhang, Robert A. Weinberg
Nature Cell Biology (2024) Vol. 26, Iss. 5, pp. 687-697
Closed Access | Times Cited: 22
Comparative Study of Transcriptomics-Based Scoring Metrics for the Epithelial-Hybrid-Mesenchymal Spectrum
Priyanka Chakraborty, Jason T. George, Shubham Tripathi, et al.
Frontiers in Bioengineering and Biotechnology (2020) Vol. 8
Open Access | Times Cited: 109
Molecular Chaperones in Cancer Stem Cells: Determinants of Stemness and Potential Targets for Antitumor Therapy
Alexander E. Kabakov, A. O. Yakimova, Olga N. Matchuk
Cells (2020) Vol. 9, Iss. 4, pp. 892-892
Open Access | Times Cited: 94
Partial EMT in head and neck cancer biology: a spectrum instead of a switch
Ananya Pal, Thomas F. Barrett, Rachel L. Paolini, et al.
Oncogene (2021) Vol. 40, Iss. 32, pp. 5049-5065
Open Access | Times Cited: 89
Notch Signaling in Breast Cancer: A Role in Drug Resistance
McKenna BeLow, Clodia Osipo
Cells (2020) Vol. 9, Iss. 10, pp. 2204-2204
Open Access | Times Cited: 88
New Insights Into the Role of Phenotypic Plasticity and EMT in Driving Cancer Progression
Sugandha Bhatia, Peiyu Wang, Alan Kie Leong Toh, et al.
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 83
Identifying inhibitors of epithelial–mesenchymal plasticity using a network topology-based approach
Kishore Hari, Burhanuddin Sabuwala, Balaram Vishnu Subramani, et al.
npj Systems Biology and Applications (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 83
A mechanistic model captures the emergence and implications of non-genetic heterogeneity and reversible drug resistance in ER+ breast cancer cells
Sarthak Sahoo, Ashutosh Mishra, Harsimran Kaur, et al.
NAR Cancer (2021) Vol. 3, Iss. 3
Open Access | Times Cited: 66
Chemokines in triple-negative breast cancer heterogeneity: New challenges for clinical implications
Umar Mehraj, Umar Mushtaq, Manzoor Ahmad Mir, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 769-783
Closed Access | Times Cited: 63
A Computational Systems Biology Approach Identifies SLUG as a Mediator of Partial Epithelial-Mesenchymal Transition (EMT)
Ayalur Raghu Subbalakshmi, Sarthak Sahoo, Kuheli Biswas, et al.
Cells Tissues Organs (2021) Vol. 211, Iss. 6, pp. 689-702
Open Access | Times Cited: 56
Chemokines and cytokines: Axis and allies in prostate cancer pathogenesis
Mohd Mughees, Jyoti Kaushal, Gunjan Sharma, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 497-512
Open Access | Times Cited: 50
Cancer-associated fibroblasts are the main contributors to epithelial-to-mesenchymal signatures in the tumor microenvironment
Péter M. Szabó, Amir Vajdi, Namit Kumar, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 31
Targeting Glucose Metabolism in Cancer Cells as an Approach to Overcoming Drug Resistance
Andrea Cunha, Patrícia Silva, Bruno Sarmento, et al.
Pharmaceutics (2023) Vol. 15, Iss. 11, pp. 2610-2610
Open Access | Times Cited: 24
Inference and multiscale model of epithelial-to-mesenchymal transition via single-cell transcriptomic data
Yutong Sha, Shuxiong Wang, Peijie Zhou, et al.
Nucleic Acids Research (2020) Vol. 48, Iss. 17, pp. 9505-9520
Open Access | Times Cited: 59
Topological signatures in regulatory network enable phenotypic heterogeneity in small cell lung cancer
Lakshya Chauhan, Uday Ram, Kishore Hari, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 55
HDAC Inhibitors: Dissecting Mechanisms of Action to Counter Tumor Heterogeneity
Dimitris Karagiannis, Θεόδωρος Ράμπιας
Cancers (2021) Vol. 13, Iss. 14, pp. 3575-3575
Open Access | Times Cited: 54
Phenotypic Heterogeneity of Triple-Negative Breast Cancer Mediated by Epithelial–Mesenchymal Plasticity
Barbora Kvokačková, Ján Remšík, Mohit Kumar Jolly, et al.
Cancers (2021) Vol. 13, Iss. 9, pp. 2188-2188
Open Access | Times Cited: 48
Chemokines orchestrate tumor cells and the microenvironment to achieve metastatic heterogeneity
Sugandha Saxena, Rakesh K. Singh
Cancer and Metastasis Reviews (2021) Vol. 40, Iss. 2, pp. 447-476
Open Access | Times Cited: 45
Epithelial-to-Mesenchymal Transition in the Light of Plasticity and Hybrid E/M States
Laura Bornes, Guillaume Belthier, Jacco van Rheenen
Journal of Clinical Medicine (2021) Vol. 10, Iss. 11, pp. 2403-2403
Open Access | Times Cited: 44
Increased heterogeneity in expression of genes associated with cancer progression and drug resistance
Anwesha Bose, Subhasis Datta, R. Mandal, et al.
Translational Oncology (2024) Vol. 41, pp. 101879-101879
Open Access | Times Cited: 6
The LSD1 inhibitor iadademstat (ORY-1001) targets SOX2-driven breast cancer stem cells: a potential epigenetic therapy in luminal-B and HER2-positive breast cancer subtypes
Elisabet Cuyàs, Juan Gumuzio, Sara Verdura, et al.
Aging (2020) Vol. 12, Iss. 6, pp. 4794-4814
Open Access | Times Cited: 49
Page 1 - Next Page

Scroll to top